Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 févr. 2026 09h00 HE | Source: Truveta

FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds

BELLEVUE, Wash., Feb. 10, 2026 (GLOBE NEWSWIRE) -- A new peer-reviewed study led by Truveta Research and collaborators finds that the US Food and Drug Administration’s (FDA) March 2024 expansion of...
07 nov. 2023 09h00 HE | Source: Adamas One Corp.

Adamas One Joins Webull’s Corporate Connect Service

SCOTTSDALE, Ariz., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that...
02 nov. 2023 09h00 HE | Source: Adamas One Corp.

Adamas One Corp Announces Initial Delivery of Lab-Grown Colorless Diamonds

Adamas One Corp Announces Initial Delivery of Lab-Grown Colorless Diamonds: Successful creation of colorless diamonds
21 déc. 2022 08h00 HE | Source: Adamas One Corp.

Adamas One Retains Patent and Trademark Counsel Protecting and Expanding its Proprietary Chemical Vapor Deposition Methodology for Laboratory Diamond Growth

SCOTTSDALE, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that...